Jens Buentzel

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study

Jens Buentzel, Oliver Micke, Irenäus A. Adamietz et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 146 citations

Oncology, Intravenous Amifostine, Radiation Therapy +8

User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center.

Jutta Huebner, Oliver Micke, Ralph Muecke et al. · PubMed · 2014 · 123 citations

Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology

Ralph Muecke, Lutz Schomburg, Michael Glatzel et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 113 citations

Radiation Medicine, Radiation Therapy, Gynecologic Radiation Oncology +9

Patients with advanced cancer and their usage of complementary and alternative medicine

Magda Paul, Brooke Davey, Bianca Senf et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 98 citations · Full text

Traditional Medicine, Advanced Cancer, Oncology +9

Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database

Orlando Guntinas‐Lichius, Thomas Wendt, Jens Buentzel et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 87 citations · Full text

Site-specific Analysis, Neck Cancer, Medicine +11